1. Home
  2. BLUE

BLUE

bluebird bio Inc.

Logo bluebird bio Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Founded: 1992 Country:
United States
United States
Employees: N/A City: SOMERVILLE
Market Cap: 212.0M IPO Year: 2013
Target Price: $5.79 AVG Volume (30 days): 8.6M
Analyst Decision: Hold Number of Analysts: 12
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.60 EPS Growth: N/A
52 Week Low/High: $0.88 - $5.53 Next Earning Date: 05-07-2024
Revenue: $21,726,000 Revenue Growth: 322.60%
Revenue Growth (this year): 900.92% Revenue Growth (next year): 245.72%

Share on Social Networks: